Title: Best Practices in RegenMed Product Development: Know Your Cost of Goods
Topic:Cell and gene therapy has grown rapidly in recent years, but challenges arise across every stage of the discovery and development process.

- By extrapolating the standard concepts of DNA engineering and applying them to therapeutic antibody development, researchers have been able to open an entirely new area for drug discovery research.
- Recently, while utilizing exogenously synthesized plasmid DNA that encodes for human monoclonal antibodies, investigators have been able to produce the immuno-molecules that target therapeutic markers for life-threatening illnesses, such as cancer.

By extrapolating the standard concepts of DNA engineering and applying them to therapeutic antibody development, researchers have been able to open an entirely new area for drug discovery research.

Recently, while utilizing exogenously synthesized plasmid DNA that encodes for human monoclonal antibodies, investigators have been able to produce the immuno-molecules that target therapeutic markers for life-threatening illnesses, such as cancer.

In this webinar, hear from two members of the clinical development and discovery research teams at Inovio discuss the design and development of their groundbreaking DNA-encoded therapeutic antibodies and how they are being employed for cancer therapies.

To learn more about Sartorius solutions for antibody discovery and development, visit us at www.sartorius.com/mab-oncology.

- How to reduce cost of goods by improving titers
- Innovative media and feed optimization strategies for CHO cell lines
- The CHOptimizer® media optimization tool box